Life Science Fund

The Life Science Fund plays a key part in nurturing the start-up ecosystem in life science fields, working with start-ups, pharmaceutical companies, and other entities to raise the standard of medical care both in Japan and worldwide, also contributing to the growth of the Japanese economy.

< Principal features >

1.MUCAP-led deal making backed by the size of its funds, one of the largest in Japan.
2.Total support by members of our specialized unit who are very familiar with these fields with regard to strategy, alliance building, and other tactics.
3.Provision of know-how and expertise through its strong track record of cooperation with pharmaceutical companies and academia.

Drug Development Ecosystem

Name	Mitsubishi UFJ Life Science II, Limited Partnership
General partner	Mitsubishi UFJ Capital
Investors	MUFG Bank and Mitsubishi UFJ Capital
Total amount	10 billion yen
Established	February 20 2019
Fund term	12 years

Name	Mitsubishi UFJ Life Science I, Limited Partnership
General partner	Mitsubishi UFJ Capital
Investors	MUFG Bank and Mitsubishi UFJ Capital
Total amount	10 billion yen
Established	February 20 2017
Fund term	12 years

Name	MUFG Medical Fund (Registered name：Mitsubishi UFJ Life Science III, Limited Partnership)
General partner	Mitsubishi UFJ Capital
Investors	MUFG Bank and Mitsubishi UFJ Capital
Total amount	10 billion yen
Established	June 22 2020
Fund term	12 years

Name	Mitsubishi UFJ Life Science IV, Limited Partnership
General partner	Mitsubishi UFJ Capital
Investors	MUFG Bank and Mitsubishi UFJ Capital
Total amount	20 billion yen
Established	March 28 2023
Fund term	12 years